From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
Weekly Wrap 25 October: Rate cuts are on the horizon: domestic consumer stock picks to consider Blog Post
Weekly Wrap 16 August: Strong Performances, Investor Reactions, and Key Trends in Week 2 of Reporting Season Blog Post
Weekly Wrap 7 June: US economy at a crossroads despite stock market surge. How to invest in a changing economy Blog Post
Weekly Wrap 12 April: Fed’s rate cut outlook is shaky as US inflation surges: What investors need to know Blog Post
Weekly Wrap 15 March: US Inflation: A silver lining? Investors pile back in despite higher numbers Blog Post